Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...

Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Wegovy launched here is to support Singapore’s efforts in improving population health: Novo Nordisk Read more at straitstimes ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.